NO991563D0 - N-substituerte azaheterosykliske forbindelser - Google Patents
N-substituerte azaheterosykliske forbindelserInfo
- Publication number
- NO991563D0 NO991563D0 NO991563A NO991563A NO991563D0 NO 991563 D0 NO991563 D0 NO 991563D0 NO 991563 A NO991563 A NO 991563A NO 991563 A NO991563 A NO 991563A NO 991563 D0 NO991563 D0 NO 991563D0
- Authority
- NO
- Norway
- Prior art keywords
- substituted azaheterocyclic
- azaheterocyclic compounds
- compounds
- substituted
- azaheterocyclic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK108996 | 1996-10-04 | ||
| PCT/DK1997/000421 WO1998015546A1 (en) | 1996-10-04 | 1997-10-02 | N-substituted azaheterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991563D0 true NO991563D0 (no) | 1999-03-30 |
| NO991563L NO991563L (no) | 1999-06-03 |
Family
ID=8100875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991563A NO991563L (no) | 1996-10-04 | 1999-03-30 | N-substituerte, azaheterosykliske forbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6569849B1 (no) |
| EP (1) | EP0934306A1 (no) |
| JP (1) | JP2001501629A (no) |
| KR (1) | KR20000048909A (no) |
| CN (1) | CN1234797A (no) |
| AU (1) | AU741839B2 (no) |
| BR (1) | BR9712202A (no) |
| CA (1) | CA2267500A1 (no) |
| CZ (1) | CZ114199A3 (no) |
| HU (1) | HUP0000088A3 (no) |
| IL (1) | IL129122A0 (no) |
| NO (1) | NO991563L (no) |
| PL (1) | PL332593A1 (no) |
| WO (1) | WO1998015546A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509346B2 (en) | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| JP2002501052A (ja) * | 1998-01-21 | 2002-01-15 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
| EP1049700B9 (en) | 1998-01-21 | 2006-05-10 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6613905B1 (en) | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7271176B2 (en) | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| TW200301698A (en) | 2001-12-21 | 2003-07-16 | Bristol Myers Squibb Co | Acridone inhibitors of IMPDH enzyme |
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| US20070066570A1 (en) * | 2003-06-16 | 2007-03-22 | Michael Solomon | Methods for treating sleep disorders |
| US20050080075A1 (en) * | 2003-08-25 | 2005-04-14 | Nichols M. James | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| EP2041088B1 (en) * | 2006-06-28 | 2014-01-08 | Amgen Inc. | Glycine transporter-1 inhibitors |
| US8034940B2 (en) | 2006-08-09 | 2011-10-11 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| SE531698C2 (sv) | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
| EP2185573A4 (en) | 2007-07-26 | 2011-12-07 | Cellay Inc | SPECIFIC PROBES OF HIGHLY VISIBLE CHROMOSOMES AND ASSOCIATED METHODS |
| US8604074B2 (en) | 2009-01-09 | 2013-12-10 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9162980B2 (en) | 2009-01-09 | 2015-10-20 | Board Of Regents Of The University Of Texas System | Anti-depression compounds |
| US8362277B2 (en) | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| WO2011153354A1 (en) | 2010-06-03 | 2011-12-08 | Cellay, Inc. | Methods and kits for in situ detection of nucleotide sequences |
| AU2011274787B2 (en) | 2010-07-07 | 2016-06-16 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| WO2013026455A1 (en) * | 2011-08-24 | 2013-02-28 | Aarhus Universitet | Permanently positively charged antidepressants |
| DK2802671T3 (en) | 2011-12-12 | 2018-11-05 | Cellay Inc | METHODS AND KITS FOR ROOM TEMPERATURE-IN SITU DETECTION OF A TARGET-NUCLEIC ACID IN A BIOLOGICAL SAMPLE |
| EP2887803A4 (en) * | 2012-08-24 | 2016-08-03 | Univ Texas | PRO-NEUROGENIC COMPOUNDS |
| EP2914737B1 (en) | 2012-10-31 | 2017-12-06 | Cellay, Inc. | Methods and kits for performing in situ hybridization |
| EP3066214B1 (en) | 2013-11-07 | 2019-10-02 | Cellay, Inc. | Methods and kits for detecting a prostate carcinoma and predicting disease outcomes for prostate cancers |
| WO2015070237A1 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective chemicals and methods for identifying and using same |
| WO2015070234A2 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective compounds and use thereof |
| CN111171006B (zh) * | 2020-01-29 | 2023-05-12 | 成都睿智化学研究有限公司 | 一种3-取代亚氨基二苄氨基类化合物的工艺方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123610A (en) * | 1964-03-03 | Alkanoylpiperidinoalkyl | ||
| US3058979A (en) * | 1957-05-13 | 1962-10-16 | Smith Kline French Lab | New perfluoroalkylphenothiazine derivatives |
| FR1212031A (fr) * | 1957-10-21 | 1960-03-21 | Rhone Poulenc Sa | Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation |
| NL100554C (no) * | 1958-04-19 | |||
| CH374682A (de) * | 1959-08-28 | 1964-01-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen |
| FR1578748A (no) * | 1967-12-28 | 1969-08-22 | ||
| DE1920170A1 (de) * | 1968-04-20 | 1970-01-29 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von N-Heterocyclischen Verbindungen |
| DK127116B (da) * | 1969-03-28 | 1973-09-24 | Ciba Geigy Ag | Analogifremgangsmåde til fremstilling af imidazolidinonderivater eller syreadditionssalte deraf. |
| FR2005201B1 (no) * | 1969-05-20 | 1973-03-16 | Auguil Ste Civile | |
| GB1323659A (en) * | 1971-04-10 | 1973-07-18 | Yoshitomi Pharmaceutical | Piperazine derivatives methods for their production and pharmaceuticl compositions containing them |
| US3828034A (en) * | 1972-05-25 | 1974-08-06 | Syntex Inc | Tricyclic pharmacological agents,intermediates and methods of making |
| FR2186249A1 (en) * | 1972-05-31 | 1974-01-11 | Synthelabo | Phenyl piperazinoalkyl (dihydro)dibenzazepines - antidepressants having low toxicity |
| US3965181A (en) * | 1973-07-06 | 1976-06-22 | Syntex (U.S.A.) Inc. | Tricyclic pharmacological agents, intermediates and methods of making |
| GB1480593A (en) * | 1973-11-30 | 1977-07-20 | Kefalas As | Xanthene and thioxanthene derivatives having pharmaceutical activity |
| DE3444837A1 (de) * | 1984-12-08 | 1986-06-12 | Basf Ag, 6700 Ludwigshafen | 10,11-dihydro-5h-dibenzo(a,d)cycloheptadien- derivate, ihre herstellung und verwendung |
| MY113463A (en) | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
| US5716949A (en) * | 1995-04-07 | 1998-02-10 | Novo Nordisk A/S | Heterocyclic compounds |
| HUP0000090A3 (en) * | 1996-10-04 | 2002-01-28 | Novo Nordisk As | 1,4-disubstituted piperazines, pharmaceutical compositions containing them, process for producing them and their use |
| US6040318A (en) * | 1997-06-25 | 2000-03-21 | Novo Nordisk A/S | Tricycle substituted with azaheterocyclic carboxylic acids |
-
1997
- 1997-10-02 WO PCT/DK1997/000421 patent/WO1998015546A1/en not_active Application Discontinuation
- 1997-10-02 AU AU43771/97A patent/AU741839B2/en not_active Ceased
- 1997-10-02 CZ CZ991141A patent/CZ114199A3/cs unknown
- 1997-10-02 IL IL12912297A patent/IL129122A0/xx unknown
- 1997-10-02 JP JP10517092A patent/JP2001501629A/ja active Pending
- 1997-10-02 HU HU0000088A patent/HUP0000088A3/hu unknown
- 1997-10-02 KR KR1019990702939A patent/KR20000048909A/ko not_active Application Discontinuation
- 1997-10-02 EP EP97941883A patent/EP0934306A1/en not_active Ceased
- 1997-10-02 CA CA002267500A patent/CA2267500A1/en not_active Abandoned
- 1997-10-02 CN CN97199183A patent/CN1234797A/zh active Pending
- 1997-10-02 BR BR9712202-5A patent/BR9712202A/pt unknown
- 1997-10-02 PL PL97332593A patent/PL332593A1/xx unknown
- 1997-10-03 US US08/943,856 patent/US6569849B1/en not_active Expired - Fee Related
-
1999
- 1999-03-30 NO NO991563A patent/NO991563L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU4377197A (en) | 1998-05-05 |
| IL129122A0 (en) | 2000-02-17 |
| WO1998015546A1 (en) | 1998-04-16 |
| AU741839B2 (en) | 2001-12-13 |
| PL332593A1 (en) | 1999-09-27 |
| HUP0000088A3 (en) | 2000-09-28 |
| CN1234797A (zh) | 1999-11-10 |
| KR20000048909A (ko) | 2000-07-25 |
| CA2267500A1 (en) | 1998-04-16 |
| HUP0000088A2 (hu) | 2000-06-28 |
| CZ114199A3 (cs) | 1999-09-15 |
| NO991563L (no) | 1999-06-03 |
| BR9712202A (pt) | 1999-08-31 |
| EP0934306A1 (en) | 1999-08-11 |
| JP2001501629A (ja) | 2001-02-06 |
| US6569849B1 (en) | 2003-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991563D0 (no) | N-substituerte azaheterosykliske forbindelser | |
| ATE271543T1 (de) | N-substituierte 2-cyanopyrrolidine | |
| ATE307112T1 (de) | N-substituierte 2-cyanopyrrolidine | |
| BR9612465A (pt) | Compostos heterocíclicos | |
| EE200000031A (et) | Uued spiroasabitsüklilised heterotsüklilised ühendid | |
| DK0820451T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| NO991564L (no) | N-substituerte azaheterosykliske forbindelser | |
| DE69531522D1 (de) | Heterozyklische Verbindungen | |
| BR9503042A (pt) | Composto de polialquilpiperidina | |
| DE59811182D1 (de) | Heterocyclische Verbindungen | |
| DE50003014D1 (de) | N-substituierte perhydrodiazine | |
| AU4376997A (en) | N-substituted azaheterocyclic compounds | |
| KR970058527U (ko) | 법면보호를 위한 블록 | |
| DK0937040T3 (da) | N-substituerede 2-cyanopyrrolidiner | |
| SE9402122D0 (sv) | Heterocyclic compounds | |
| SE9400968D0 (sv) | Heterocyclic compounds | |
| DK0851865T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| FIU960481U0 (fi) | Pakkaus joulukuusta varten | |
| NO934473L (no) | N-substituerte azabicykloheptanderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |